03:50:26 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-08 Kvartalsrapport 2024-Q3
2024-08-23 Kvartalsrapport 2024-Q2
2024-05-14 Kvartalsrapport 2024-Q1
2024-04-29 Ordinarie utdelning OMDA 0.48 NOK
2024-04-25 Årsstämma 2024
2024-03-01 Bokslutskommuniké 2023
2023-11-10 Kvartalsrapport 2023-Q3
2023-09-26 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-12 Kvartalsrapport 2023-Q1
2023-04-28 Ordinarie utdelning OMDA 0.00 NOK
2023-04-27 Årsstämma 2023
2023-02-28 Bokslutskommuniké 2022
2022-11-30 Kvartalsrapport 2022-Q3
2022-10-03 Extra Bolagsstämma 2022
2022-08-30 Kvartalsrapport 2022-Q2
2022-05-20 Ordinarie utdelning OMDA 0.00 NOK
2022-05-19 Kvartalsrapport 2022-Q1
2022-05-19 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-31 Kvartalsrapport 2021-Q2
2021-05-26 Kvartalsrapport 2021-Q1
2021-05-07 Ordinarie utdelning OMDA 0.00 NOK
2021-05-06 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-12-11 Extra Bolagsstämma 2020
2020-11-27 Kvartalsrapport 2020-Q3

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorInformationsteknik
IndustriProgramvara
OMDA är verksamma inom teknikbranschen. Bolaget är specialiserade inom utveckling av digitala plattformar för vården. Programvaran är egenutvecklad och används huvudsakligen för analys och uppföljning av olika områden inom sjukvården. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Verksamhet innehas på global nivå med störst närvaro inom den europeiska marknaden.
2023-08-25 08:00:00
Oslo, Norway, 25 August 2023: Today, CSAM Health Group AS (CSAM), a leading
provider of specialised software for healthcare, published its results for the
second quarter of 2023.

CSAM Health Group continues to grow and reported revenues of NOK 104 million for
Q2-23, a 16% increase over Q2-22. Recurring revenue saw a similar growth rate
and reached NOK 82 million in Q2-23, up from 70 million for the same period last
year.

CSAM CEO Sverre Flatby highlights the healthy and steady growth: "The revenue
year-to-date reached NOK 206.3 million, and we are on track to reach our target
of passing the NOK 400 million mark for the year. We are proud to be on the
trajectory to reach that revenue milestone, while also seeing our EBITDA margin
continuing its positive development. After the implementation of the cost
reduction programme earlier this year, we saw EBITDA margins turn positive to 5%
in Q1-23, and last quarter it reached 10%."

CSAM's growth in recurring revenue originates from a solid fundament of
long-term contracts in several countries. It also covers all of CSAM's business
areas, making it a diversified revenue stream with minor customer churn.

"We are optimistic that our cost reduction programme will continue to yield
results, and we expect EBITDA margins for our existing businesses to steadily
increase towards the 30% target. In addition, our ambition to grow through M&A
remains central to our strategy, and we are continuously in dialogue with
interesting parties," concludes Flatby.

Highlights from the report:
o Q2-23 total income 104 MNOK vs 90 MNOK in Q2-22
o Recurring revenue grew 16% to 82 MNOK (Q2-23 vs Q2-22), and accounted for 79%
of total sales
o Reported EBITDA was 11 MNOK resulting in a 10% EBITDA margin
o Q2-23 organic growth of 10.6% vs Q2-22 in local currency (15.1% in NOK)
o Gross margin increased to 91% (90%)

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare
in the Nordics. From this solid foundation the company has grown to serve more
than 500 customers in 27 countries. Our highly specialised software solutions
are instrumental in the clinical care processes of healthcare providers and in
enabling emergency responders to enhance public safety. CSAM's headquarters are
in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries
across Europe, Asia, Oceania and North America, including a wholly-owned
software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH